Genes
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
85,013 comparisons from ClinicalTrials.gov. Counted 2026-11-10.
Most participants first33,758 with no events in either group come last441 to 460 of 85,013
| Comparison | With the outcome | Risk difference, 95% interval | Participants | Trial |
|---|---|---|---|---|
| TICAGRELOR vs CLOPIDOGREL: Participants With Any Event From the Composite of Death From Vascular Causes, Myocardial Infarction (MI), and Stroke | 864 of 9,333 1,014 of 9,291 | -1.7 points -2.5 to -0.8 | 18,624 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| TICAGRELOR vs CLOPIDOGREL: Participants With Death From Any Cause | 399 of 9,333 506 of 9,291 | -1.2 points -1.8 to -0.6 | 18,624 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| TICAGRELOR vs CLOPIDOGREL: Participants With Any Event From the Composite of All-cause Mortality, MI, and Stroke | 901 of 9,333 1,065 of 9,291 | -1.8 points -2.7 to -0.9 | 18,624 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| MVA-BN-RSV vs Placebo: deaths from any cause | 41 of 9,389 34 of 9,191 | 0.1 points -0.1 to 0.3 | 18,580 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: serious adverse events | 517 of 9,389 422 of 9,191 | 0.9 points 0.3 to 1.5 | 18,580 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| TICAGRELOR vs CLOPIDOGREL: Participants With Any Major Bleeding Event | 961 of 9,235 929 of 9,186 | 0.3 points -0.6 to 1.2 | 18,421 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| TICAGRELOR vs CLOPIDOGREL: Participants With Non-CABG (Coronary Artery Bypass Graft) Related Major Bleeding | 362 of 9,235 306 of 9,186 | 0.6 points 0.0 to 1.1 | 18,421 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| TICAGRELOR vs CLOPIDOGREL: Participants With Major or Minor Bleeding | 1,339 of 9,235 1,215 of 9,186 | 1.3 points 0.3 to 2.3 | 18,421 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| TICAGRELOR vs CLOPIDOGREL: Participants With Non-procedural Major Bleeding | 235 of 9,235 180 of 9,186 | 0.6 points 0.2 to 1.0 | 18,421 | NCT00391872 A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
| MVA-BN-RSV vs Placebo: Number of Participants With Serious Adverse Events | 517 of 9,389 422 of 8,959 | 0.8 points 0.2 to 1.4 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Occurrence of Severe PCR Confirmed RSV-associated LRTD | 0 of 9,160 2 of 9,188 | -0.0 points -0.1 to 0.0 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Number of Participants With Unsolicited Adverse Events | 607 of 9,389 581 of 8,959 | -0.0 points -0.7 to 0.7 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Occurrence of PCR Confirmed RSV-associated LRTD With at Least 3 Symptoms | 12 of 9,160 21 of 9,188 | -0.1 points -0.2 to 0.0 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Occurrence of Complications Related to PCR-confirmed RSV Disease | 0 of 9,160 1 of 9,188 | -0.0 points -0.1 to 0.0 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Number of Participants With Grade 3 or Higher Adverse Events | 11 of 9,389 2 of 8,959 | 0.1 points 0.0 to 0.2 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Occurrence of Hospitalization Due to Confirmed RSV Disease or Due to Any Complication Related to RSV-confirmed Respiratory Disease | 0 of 9,160 1 of 9,188 | -0.0 points -0.1 to 0.0 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Occurrence of PCR Confirmed RSV-associated ARD | 42 of 9,160 82 of 9,188 | -0.4 points -0.7 to -0.2 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| MVA-BN-RSV vs Placebo: Occurrence of PCR Confirmed RSV-associated LRTD With at Least 2 Symptoms | 25 of 9,160 61 of 9,188 | -0.4 points -0.6 to -0.2 | 18,348 | NCT05238025 MVA-BN-RSV Vaccine Trial |
| Clinical Decision Support (Cardiovascular Wizard) vs Usual Care: deaths from any cause | 207 of 10,775 159 of 7,454 | -0.2 points -0.6 to 0.2 | 18,229 | NCT02759055 Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard) |
| Clinical Decision Support (Cardiovascular Wizard) vs Usual Care: serious adverse events | 1,836 of 10,775 1,360 of 7,454 | -1.2 points -2.3 to -0.1 | 18,229 | NCT02759055 Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard) |
Response
The first 2 of this page's 20 results. GET /api/comparisons/v1?page=23
{
"data": {
"total": 85013,
"results": [
{
"id": "NCT00391872-3d94e6dd",
"title": "TICAGRELOR vs CLOPIDOGREL: Participants With Any Event From the Composite of Death From Vascular Causes, Myocardial Infarction (MI), and Stroke",
"summary": "864 of 9333 against 1014 of 9291; risk difference -1.7 points, 95% interval -2.5 to -0.8; NCT00391872, A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome",
"record": "/library/comparisons/NCT00391872-3d94e6dd",
"nct_id": "NCT00391872",
"kind": "outcome",
"participants": 18624,
"risk_difference": {
"value": -0.016563140551297192,
"lower": -0.02521936097207644,
"upper": -0.007915809832015229
},
"group_1": "864 of 9,333",
"group_2": "1,014 of 9,291",
"difference": "-1.7 points",
"interval": "-2.5 to -0.8",
"trial_title": "A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome"
},
{
"id": "NCT00391872-51df9737",
"title": "TICAGRELOR vs CLOPIDOGREL: Participants With Death From Any Cause",
"summary": "399 of 9333 against 506 of 9291; risk difference -1.2 points, 95% interval -1.8 to -0.6; NCT00391872, A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome",
"record": "/library/comparisons/NCT00391872-51df9737",
"nct_id": "NCT00391872",
"kind": "outcome",
"participants": 18624,
"risk_difference": {
"value": -0.011709779800590923,
"lower": -0.017907613325256852,
"upper": -0.005536972646425837
},
"group_1": "399 of 9,333",
"group_2": "506 of 9,291",
"difference": "-1.2 points",
"interval": "-1.8 to -0.6",
"trial_title": "A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome"
}
],
"no_events": 33758,
"columns": [
{
"key": "title",
"label": "Comparison"
},
{
"key": "group_1",
"label": "With the outcome",
"under": "group_2"
},
{
"key": "difference",
"label": "Risk difference, 95% interval",
"under": "interval"
},
{
"key": "participants",
"label": "Participants"
},
{
"key": "nct_id",
"label": "Trial",
"under": "trial_title"
}
],
"order": "Most participants first",
"kinds": {
"all": 85013,
"outcome": 33568,
"serious-adverse-events": 31897,
"deaths": 19548
}
},
"release": "trial-comparisons-2026-03-23-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
"short": "None stated"
}
],
"next": "/api/comparisons/v1?page=24",
"request_id": "bLuRUrv4y55mmGk1"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
NCBI Gene
One gene with its proteins, patents, drugs, trials, grants and papers.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/comparisons/v1. No key.
GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome
Ask an assistant